metanephrine has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arlt, W; Beuschlein, F; Eisenhofer, G; Januszewicz, A; Kroiß, M; Peitzsch, M; Prejbisz, A; Siegert, G | 1 |
| Doherty, GM; Hammer, GD; Strosberg, JR | 1 |
2 other study(ies) available for metanephrine and Neoplasm Metastasis
| Article | Year |
|---|---|
Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Dopamine; Female; Humans; Male; Metanephrine; Middle Aged; Neoplasm Metastasis; Normetanephrine; Paraganglioma; Pheochromocytoma; Reproducibility of Results; Tandem Mass Spectrometry; Young Adult | 2013 |
Management of adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Catecholamines; Chemotherapy, Adjuvant; Cushing Syndrome; Diagnostic Imaging; Humans; Hydrocortisone; Metanephrine; Mitotane; Neoplasm Metastasis; Neoplasm Staging; Prognosis | 2009 |